ICCC (ImmuCell Corp) Total Aset Perusahaan

The price visualization available on the GURU.Markets page demonstrates that the total assets of ImmuCell Corporation (ICCC) amount to 46.75. ImmuCell Corporation (ICCC) holds a leading position in veterinary immunology, developing high-demand health protection products for calves. The production cycle is based on highly automated lines utilizing AI for test quality control. A stable cash flow from the sale of biological products allows the company to confidently maintain its current liquidity.

Total assets measure the aggregate resource potential of a business, combining equity and liabilities to assess the scale of control over property. By analyzing the asset history of ImmuCell Corporation (ICCC), reverse-calculated via return on assets (ROA), an investor can identify the material base, which in the case of ImmuCell Corporation (ICCC) is bolstered by unique production capacities for veterinary immunopreparations that create a high barrier to entry for competitors.